X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (90206) 90206
Magazine Article (849) 849
Newsletter (408) 408
Newspaper Article (398) 398
Book Chapter (216) 216
Book / eBook (124) 124
Conference Proceeding (50) 50
Book Review (35) 35
Dissertation (35) 35
Web Resource (32) 32
Publication (21) 21
Reference (17) 17
Transcript (12) 12
Trade Publication Article (9) 9
Journal / eJournal (6) 6
Government Document (4) 4
Streaming Video (4) 4
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (68415) 68415
male (38558) 38558
anti-inflammatory agents - therapeutic use (37136) 37136
female (33861) 33861
anti-inflammatory agents, non-steroidal - therapeutic use (27377) 27377
animals (26502) 26502
adult (20382) 20382
middle aged (19563) 19563
pharmacology & pharmacy (13715) 13715
inflammation (13518) 13518
aged (13469) 13469
treatment outcome (11848) 11848
anti-inflammatory agents - pharmacology (10402) 10402
mice (9767) 9767
rats (9411) 9411
anti-inflammatory agents, non-steroidal - adverse effects (8336) 8336
anti-inflammatory agents - administration & dosage (7457) 7457
adolescent (7422) 7422
anti-inflammatory agents, non-steroidal - administration & dosage (6187) 6187
nonsteroidal anti-inflammatory drugs (6033) 6033
anti-inflammatory agents, non-steroidal - pharmacology (5809) 5809
child (5688) 5688
care and treatment (5513) 5513
drug therapy, combination (5389) 5389
analysis (5325) 5325
risk factors (5292) 5292
disease models, animal (5257) 5257
immunology (5061) 5061
medicine, general & internal (5030) 5030
inflammation - drug therapy (4955) 4955
double-blind method (4923) 4923
rheumatology (4916) 4916
time factors (4882) 4882
gastroenterology & hepatology (4644) 4644
research (4487) 4487
anti-inflammatory drugs (4478) 4478
dose-response relationship, drug (4423) 4423
pain (4350) 4350
nonsteroidal antiinflammatory drugs (4328) 4328
cytokines (4289) 4289
therapy (4257) 4257
health aspects (4227) 4227
arthritis, rheumatoid - drug therapy (4213) 4213
double-blind (4147) 4147
drug therapy (4090) 4090
anti-inflammatory agents - adverse effects (4066) 4066
expression (4042) 4042
administration, topical (4034) 4034
chemistry, medicinal (3819) 3819
immunosuppressive agents - therapeutic use (3803) 3803
medicine & public health (3764) 3764
surgery (3737) 3737
disease (3691) 3691
anti-inflammatory agents (3646) 3646
aged, 80 and over (3431) 3431
retrospective studies (3377) 3377
arthritis (3346) 3346
prospective studies (3304) 3304
oxidative stress (3295) 3295
prednisolone - therapeutic use (3252) 3252
follow-up studies (3220) 3220
rheumatoid-arthritis (3165) 3165
rats, wistar (3148) 3148
dermatology (3124) 3124
inhibition (3119) 3119
young adult (3119) 3119
diagnosis, differential (3112) 3112
clinical trials as topic (3059) 3059
steroids (3058) 3058
corticosteroids (2990) 2990
child, preschool (2967) 2967
aspirin - therapeutic use (2890) 2890
severity of illness index (2881) 2881
rats, sprague-dawley (2867) 2867
anti-inflammatory (2855) 2855
prednisone - therapeutic use (2830) 2830
drugs (2828) 2828
clinical neurology (2811) 2811
activation (2808) 2808
administration, oral (2806) 2806
adrenal cortex hormones - therapeutic use (2795) 2795
analgesics - therapeutic use (2757) 2757
efficacy (2743) 2743
neurosciences (2741) 2741
nf-kappa-b (2728) 2728
biochemistry & molecular biology (2719) 2719
pain - drug therapy (2717) 2717
management (2702) 2702
research article (2687) 2687
anti-bacterial agents - therapeutic use (2660) 2660
glucocorticoids - therapeutic use (2642) 2642
pediatrics (2626) 2626
aspirin (2614) 2614
risk (2610) 2610
medicine (2591) 2591
cancer (2563) 2563
apoptosis (2561) 2561
plant extracts - pharmacology (2549) 2549
infliximab (2534) 2534
rodents (2533) 2533
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (79) 79
Online Resources - Online (28) 28
Collection Dvlpm't (Acquisitions) - Closed Orders (4) 4
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
Sunnybrook Health Sciences Centre - Holland Stacks (3) 3
UofT at Mississauga - Stacks (3) 3
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (81765) 81765
German (2594) 2594
French (2463) 2463
Japanese (1255) 1255
Russian (1143) 1143
Spanish (1051) 1051
Italian (949) 949
Polish (425) 425
Chinese (400) 400
Dutch (238) 238
Portuguese (146) 146
Romanian (129) 129
Danish (128) 128
Hungarian (103) 103
Czech (92) 92
Finnish (89) 89
Norwegian (84) 84
Swedish (78) 78
Croatian (74) 74
Korean (67) 67
Ukrainian (62) 62
Bulgarian (53) 53
Hebrew (50) 50
Turkish (44) 44
Serbian (26) 26
Slovak (24) 24
Lithuanian (21) 21
Arabic (5) 5
Bosnian (4) 4
Afrikaans (3) 3
Greek (3) 3
Icelandic (2) 2
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The lancet oncology, ISSN 1470-2045, 2011, Volume 12, Issue 5, pp. 496 - 503
Summary In March, 2010, a group of breast cancer experts met to develop a consensus statement on breast cancer prevention, with a focus on medical and therapeutic interventions... 
Hematology, Oncology and Palliative Medicine | ZOLEDRONIC ACID | SURGICAL ADJUVANT BREAST | ONCOLOGY | STATIN USE | LOW-DOSE TAMOXIFEN | RANDOMIZED-TRIAL | FOLLOW-UP | RISK | BOWEL PROJECT | POSTMENOPAUSAL WOMEN | GENOME-WIDE ASSOCIATION | Thiophenes - therapeutic use | Metformin - therapeutic use | Raloxifene Hydrochloride - therapeutic use | Humans | Selective Estrogen Receptor Modulators - adverse effects | Tetrahydronaphthalenes - therapeutic use | Pyrrolidines - therapeutic use | Antineoplastic Agents, Hormonal - adverse effects | Aromatase Inhibitors - adverse effects | Estrogen Receptor Modulators - therapeutic use | Retinoids - therapeutic use | Selective Estrogen Receptor Modulators - therapeutic use | Antineoplastic Agents, Hormonal - therapeutic use | Diphosphonates - therapeutic use | Female | Aromatase Inhibitors - therapeutic use | Estrogen Receptor Modulators - adverse effects | Anticarcinogenic Agents - therapeutic use | Triazoles - therapeutic use | Premenopause | Anastrozole | Consensus Development Conferences as Topic | Breast Neoplasms - prevention & control | Fenretinide - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Piperidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Tamoxifen - therapeutic use | Androstadienes - therapeutic use | Expert Testimony | Norpregnenes - therapeutic use | Nitriles - therapeutic use | COX-2 inhibitors | Care and treatment | Aspirin | Oncology, Experimental | Menopause | Phosphonates | Breast cancer | Retinoids | Research | Tamoxifen | Prevention | Analysis | Health aspects | Cancer
Journal Article
International journal of molecular sciences, ISSN 1422-0067, 2016, Volume 17, Issue 9, pp. 1534 - 1534
Journal Article
Journal Article
Mini-Reviews in Medicinal Chemistry, ISSN 1389-5575, 2013, Volume 13, Issue 2, pp. 163 - 193
.... This work resumes the available and up to date work done on members of the Piperaceae family and their uses for therapeutic purposes. Methods... 
Pharmacological actions | Piperaceae | Complementary medicine | Phytochemical constituents | Piper | OXIDATIVE STRESS | CHEMISTRY, MEDICINAL | LIPID-PEROXIDATION | ALZHEIMERS-DISEASE | LARVICIDAL ACTIVITY | LUNG CARCINOGENESIS | ORAL SUPPLEMENTATION | B16F-10 MELANOMA-CELLS | IN-VITRO | pharmacological actions | complementary medicine | HEALTHY-VOLUNTEERS | phytochemical constituents | CYTOTOXIC PYRIDONE ALKALOIDS | Anti-Infective Agents - toxicity | Central Nervous System Agents - therapeutic use | Plant Extracts - chemistry | Plant Extracts - toxicity | Antioxidants - chemistry | Obesity - drug therapy | Plant Extracts - pharmacology | Anti-Infective Agents - pharmacology | Cardiovascular Diseases - drug therapy | Humans | Platelet Aggregation Inhibitors - toxicity | Anti-Obesity Agents - therapeutic use | Anti-Obesity Agents - toxicity | Anti-Infective Agents - chemistry | Anti-Inflammatory Agents - therapeutic use | Platelet Aggregation Inhibitors - pharmacology | Antineoplastic Agents, Phytogenic - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Alkaloids - toxicity | Alkaloids - pharmacology | Central Nervous System Agents - chemistry | Anti-Inflammatory Agents - pharmacology | Anti-Inflammatory Agents - toxicity | Anti-Infective Agents - therapeutic use | Antineoplastic Agents, Phytogenic - chemistry | Cardiovascular Agents - toxicity | Antioxidants - pharmacology | Cognition Disorders - drug therapy | Piper - chemistry | Cardiovascular Agents - pharmacology | Neoplasms - drug therapy | Antineoplastic Agents, Phytogenic - toxicity | Antioxidants - toxicity | Cardiovascular Agents - therapeutic use | Anti-Obesity Agents - chemistry | Antioxidants - therapeutic use | Animals | Anti-Inflammatory Agents - chemistry | Central Nervous System Agents - pharmacology | Platelet Aggregation Inhibitors - chemistry | Alkaloids - therapeutic use | Antineoplastic Agents, Phytogenic - pharmacology | Anti-Obesity Agents - pharmacology | Plant Extracts - therapeutic use | Alkaloids - chemistry | Central Nervous System Agents - toxicity | Cardiovascular Agents - chemistry
Journal Article
Molecules (Basel, Switzerland), ISSN 1420-3049, 2016, Volume 21, Issue 8, p. 991
Phenylethanoid glycosides (PhGs) are widely distributed in traditional Chinese medicines as well as in other medicinal plants, and they were characterized by a... 
Bioactivity | Pharmacokinetics | Novel structures | Phenylethanoid glycosides | CISTANCHE-SALSA EXTRACT | ALZHEIMERS-DISEASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | novel structures | TANDEM MASS-SPECTROMETRY | CHEMISTRY, MULTIDISCIPLINARY | PERFORMANCE LIQUID-CHROMATOGRAPHY | phenylethanoid glycosides | VITRO ANTIINFLAMMATORY ACTIVITY | IN-VITRO | bioactivity | FORSYTHIA-SUSPENSA | METABOLITE P-TYROSOL | LC-MS/MS METHOD | pharmacokinetics | RAT PLASMA | Neuroprotective Agents - therapeutic use | Antioxidants - chemistry | Antiviral Agents - pharmacokinetics | Immunologic Factors - isolation & purification | Anti-Bacterial Agents - therapeutic use | Immunologic Factors - pharmacokinetics | Neuroprotective Agents - pharmacokinetics | Antiviral Agents - chemistry | Anti-Bacterial Agents - chemistry | Glycosides - isolation & purification | Anti-Inflammatory Agents - therapeutic use | Anti-Inflammatory Agents - pharmacokinetics | Anti-Inflammatory Agents - isolation & purification | Drugs, Chinese Herbal - therapeutic use | Glycosides - chemistry | Immunologic Factors - chemistry | Plants, Medicinal - chemistry | Neuroprotective Agents - chemistry | Antiviral Agents - therapeutic use | Phenylethyl Alcohol - pharmacokinetics | Anti-Bacterial Agents - isolation & purification | Phenylethyl Alcohol - isolation & purification | Drugs, Chinese Herbal - pharmacokinetics | Antioxidants - therapeutic use | Anti-Inflammatory Agents - chemistry | Neuroprotective Agents - isolation & purification | Antioxidants - isolation & purification | Drugs, Chinese Herbal - chemistry | Anti-Bacterial Agents - pharmacokinetics | Glycosides - pharmacokinetics | Antioxidants - pharmacokinetics | Antiviral Agents - isolation & purification | Phenylethyl Alcohol - therapeutic use | Glycosides - therapeutic use | Immunologic Factors - therapeutic use | Phenylethyl Alcohol - chemistry
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 05/2017, Volume 2019, Issue 10, p. CD003280
.... This review was first published in 2003 and has been updated most recently in 2016. Objectives To assess the effects of immunomodulatory and immunosuppressive agents other than corticosteroids, immunoglobulin, and plasma exchange in CIDP... 
Immunologic Factors | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | Chronic inflammatory demyelinating polyradiculopathy | Immunosuppressive Agents | Chronic inflammatory demyelinating polyradiculoneuropathy | Interferon beta‐1a | Treatment Outcome | Immunosuppressive and immunomodulatory treatment | Randomized Controlled Trials as Topic | Neurology | Interferon‐beta | Anti‐Inflammatory Agents | Azathioprine | Methotrexate | Medicine General & Introductory Medical Sciences | Immunoglobulins, Intravenous | Peripheral Neuropathy | SYSTEMIC-LUPUS-ERYTHEMATOSUS | Interferon-beta [therapeutic use] | Immunologic Factors [therapeutic use] | Humans | GUILLAIN-BARRE-SYNDROME | Immunosuppressive Agents [therapeutic use] | Anti-Inflammatory Agents [therapeutic use] | Azathioprine [therapeutic use] | RANDOMIZED CONTROLLED TRIAL | DISEASE-MODIFYING THERAPY | MEDICINE, GENERAL & INTERNAL | Interferon beta-1a | HIGH-DOSE CYCLOPHOSPHAMIDE | INTRAVENOUS IMMUNOGLOBULIN | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating [drug therapy] | TERM-FOLLOW-UP | PLACEBO-CONTROLLED TRIAL | STEM-CELL TRANSPLANTATION | Methotrexate [therapeutic use] | MYCOPHENOLATE-MOFETIL | Interferon-beta - therapeutic use | Azathioprine - therapeutic use | Interferon beta-1a - therapeutic use | Immunoglobulins, Intravenous - therapeutic use | Immunosuppressive Agents - therapeutic use | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - drug therapy | Anti-Inflammatory Agents - therapeutic use | Methotrexate - therapeutic use | Immunologic Factors - therapeutic use
Journal Article
Molecules (Basel, Switzerland), ISSN 1420-3049, 2016, Volume 21, Issue 3, p. 264
Nowadays, there are some molecules that have shown over the years a high capacity to act against relevant pathologies such as cardiovascular disease,... 
Lung diseases | Liver disorders | ROS | Curcumin | Bioavailability | Natural compound | Antioxidant | Cardiovascular diseases | Anti-inflammatory | Cancer | lung diseases | antioxidant | OXIDATIVE STRESS | BIOCHEMISTRY & MOLECULAR BIOLOGY | natural compound | CHEMOPREVENTIVE AGENT CURCUMIN | cardiovascular diseases | ALLERGIC AIRWAY INFLAMMATION | INDUCED LIPID-PEROXIDATION | I CLINICAL-TRIAL | CHEMISTRY, MULTIDISCIPLINARY | HUMAN COLORECTAL-CANCER | TUMOR-NECROSIS-FACTOR | bioavailability | liver disorders | INDUCED PULMONARY-FIBROSIS | anti-inflammatory | cancer | GLUTATHIONE-S-TRANSFERASE | NF-KAPPA-B | curcumin | Neuroprotective Agents - therapeutic use | Cardiovascular Diseases - drug therapy | Humans | Biological Availability | Curcumin - chemical synthesis | Neurodegenerative Diseases - drug therapy | Cardiotonic Agents - therapeutic use | Cardiotonic Agents - chemical synthesis | Anti-Inflammatory Agents - therapeutic use | Anti-Inflammatory Agents - isolation & purification | Antineoplastic Agents, Phytogenic - therapeutic use | Antineoplastic Agents, Phytogenic - chemical synthesis | Curcumin - therapeutic use | Curcumin - isolation & purification | Inflammation | Antioxidants - chemical synthesis | Neoplasms - drug therapy | Antioxidants - therapeutic use | Neuroprotective Agents - chemical synthesis | Animals | Cardiotonic Agents - isolation & purification | Neuroprotective Agents - isolation & purification | Antioxidants - isolation & purification | Anti-Inflammatory Agents - chemical synthesis | Plants, Medicinal | Antineoplastic Agents, Phytogenic - isolation & purification | Curcuma - chemistry
Journal Article